SEARCH NEWS & VIEWS


Team Shows ‘Bath Salts’ Stimulant Could Be More Addictive than Meth
Scientists Turn Muscular Dystrophy Defect On and Off in Cells
Researchers Design a Potential Drug Compound that Attacks Parkinson’s Disease on Two Fronts
Tiny RNA Molecules Shed Light on Immune Response

NEWS & VIEWS HOME
PAST ISSUES
KUDOS
SCIENTIFIC CALENDAR
CA AUDITORIUM EVENTS
CONTACT




FOLLOW US
1
Team Shows ‘Bath Salts’ Stimulant Could Be More Addictive than Meth

The findings from the Taffe and Dickerson labs underline the drug’s potential dangers.

Scientists Turn Muscular Dystrophy Defect On and Off in Cells

“This easy approach is an entirely new way to turn a genetic defect off or on,” says Associate Professor Matthew Disney.

Researchers Design a Potential Drug Compound that Attacks Parkinson’s Disease on Two Fronts

The LoGrasso lab’s “dual inhibitor”—two compounds in a single molecule—attacks a pair of proteins closely associated with development of Parkinson’s.

Tiny RNA Molecules Shed Light on Immune Response

The findings from the Xiao lab could have medical applications from viral vaccines to treatments for autoimmune diseases.

  • New Compound Excels at Killing Persistent and Drug-Resistant Tuberculosis
  • Unusual Antibodies in Cows Suggest New Ways to Make Therapies for People
  • Scientists Develop Powerful New Method for Finding Therapeutic Antibodies
  • Dan Salomon Embraces the Complexity of Transplant Medicine
  • TSRI Celebrates 21st Commencement
  • Preclinical Study Shows Heroin Vaccine Blocks Relapse
  • Team Finds Dissimilar Proteins Evolved Similar 7-Part Shape
  • Scientists Find Antibody that Transforms Bone Marrow Stem Cells Directly into Brain Cells
  • Scientists Help Unravel a Central Mystery of Alzheimer’s Disease
  • Team Finds Interferon, One of the Body’s Own Proteins, Induces Persistent Viral Infection
  • New Vaccine-Design Approach Targets HIV and Other Fast-Mutating Viruses
  • Scientists Identify First Potentially Effective Therapy for Human Prion Disease
  • Study Reveals How Serotonin Receptors Can Shape Drug Effects from LSD to Migraine Medication
  • Philanthropist John Moores Gives $2 Million to TSRI to Develop River Blindness Field Test